Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases

Introduction: Prolactinomas are preferentially treated with dopamine agonists. However, a few adenomas are resistant to this treatment. Objective: To evaluate the characteristics of patients with resistance to dopamine agonists in the long-term. Method: A retrospective study of six cases was made. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzaga, Maria de Fátima de Magalhães, de Castro, Lucas Faria, Naves, Luciana Ansaneli, Mendonça, José Luiz, Oton de Lima, Benicio, Kessler, Iruena, Casulari, Luiz Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277870/
https://www.ncbi.nlm.nih.gov/pubmed/30542321
http://dx.doi.org/10.3389/fendo.2018.00625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277870/
https://www.ncbi.nlm.nih.gov/pubmed/30542321
http://dx.doi.org/10.3389/fendo.2018.00625

Ejemplares similares